다이토제약(주): 손익 계산서 (TTM)

다이토제약(주)
JP ˙ TSE ˙ JP3486150000
JP¥1,154.00 ↑23.00 (2.03%)
2026-06-05
주가
손익 계산서 (TTM)

다이토제약(주) 손익 계산서(Income Statement)에는 일정 기간 동안의 소득 및 지출 변화가 표시됩니다. 손익 계산서 데이터에는 판매액(Sales), 매출액(Revenue), 총이익(Gross Profit), 연구개발(R&D), 판매 및 관리비(SG&A: Selling, General and Administrative Expense), 영업이익(Operating Income), 소득세 비용, 이자 비용, 비영업이익, 주당이익(EPS: Earnings per Share) 및 발행 주식수로 구성됩니다.

모든 수치는 지분 단위당 1,000,000 제외의 곱입니다.123456

2021
08-31
2021
11-30
2022
02-28
2022
05-31
2022
08-31
2022
11-30
2023
02-28
2023
05-31
2023
08-31
2023
11-30
2024
02-29
2024
05-31
2024
08-31
2024
11-30
2025
02-28
2025
05-31
2025
08-31
2025
11-30
2026
02-28
수익 46,757 45,142 44,462 43,464 43,759 44,368 44,451 45,101 45,238 45,844 45,193 46,895 47,395 47,369 48,842 50,643 50,976 51,200 50,766
변화 (%) -3.45 -1.51 -2.24 0.68 1.39 0.19 1.46 0.30 1.34 -1.42 3.77 1.07 -0.05 3.11 3.69 0.66 0.44 -0.85
수익의 % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
매출원가 35,828 34,136 33,413 32,005 32,798 33,550 34,151 34,770 35,210 35,740 35,529 37,056 37,781 38,341 39,922 42,005 42,030 42,176 41,387
변화 (%) -4.72 -2.12 -4.21 2.48 2.29 1.79 1.81 1.27 1.51 -0.59 4.30 1.96 1.48 4.12 5.22 0.06 0.35 -1.87
수익의 % 76.63 75.62 75.15 73.64 74.95 75.62 76.83 77.09 77.83 77.96 78.62 79.02 79.72 80.94 81.74 82.94 82.45 82.38 81.53
총 영업 이익 10,929 11,006 11,049 11,459 10,961 10,818 10,300 10,331 10,028 10,104 9,664 9,839 9,614 9,028 8,920 8,638 8,946 9,024 9,379
변화 (%) 0.70 0.39 3.71 -4.35 -1.30 -4.79 0.30 -2.93 0.76 -4.35 1.81 -2.29 -6.10 -1.20 -3.16 3.57 0.87 3.93
수익의 % 23.37 24.38 24.85 26.36 25.05 24.38 23.17 22.91 22.17 22.04 21.38 20.98 20.28 19.06 18.26 17.06 17.55 17.62 18.47
판매관리비 2,436 2,561 2,658 2,990 3,349 3,399 3,372 3,078 3,196 3,388 3,412 3,431 3,438 3,438 3,748 3,333 6,175 3,564 5,874
변화 (%) 5.13 3.79 12.49 12.01 1.49 -0.79 -8.72 3.83 6.01 0.71 0.56 0.20 0.00 9.02 -11.07 85.27 -42.28 64.81
수익의 % 5.21 5.67 5.98 6.88 7.65 7.66 7.59 6.82 7.06 7.39 7.55 7.32 7.25 7.26 7.67 6.58 12.11 6.96 11.57
연구개발 2,032 2,032 2,032 1,749 1,749 1,749 1,749 1,865 1,865 1,865 1,865 2,349 2,349 2,349 2,349 2,520 2,520
변화 (%) 0.00 0.00 -13.93 0.00 0.00 0.00 6.63 0.00 0.00 0.00 25.95 0.00 0.00 0.00 7.28
수익의 % 4.35 4.50 4.57 4.02 4.00 3.94 3.93 4.14 4.12 4.07 4.13 5.01 4.96 4.96 4.81 4.98 4.92
운영 비용 40,428 38,861 38,235 36,896 38,048 38,850 39,424 39,889 40,447 41,169 40,982 43,001 43,733 44,293 46,184 48,022 48,205 48,424 47,261
변화 (%) -3.88 -1.61 -3.50 3.12 2.11 1.48 1.18 1.40 1.79 -0.45 4.93 1.70 1.28 4.27 3.98 0.38 0.45 -2.40
수익의 % 86.46 86.09 85.99 84.89 86.95 87.56 88.69 88.44 89.41 89.80 90.68 91.70 92.27 93.51 94.56 94.82 94.56 94.58 93.10
영업 이익 6,329 6,281 6,227 6,568 5,711 5,518 5,027 5,212 4,791 4,675 4,211 3,894 3,662 3,076 2,658 2,621 2,771 2,776 3,505
변화 (%) -0.76 -0.86 5.48 -13.05 -3.38 -8.90 3.68 -8.08 -2.42 -9.93 -7.53 -5.96 -16.00 -13.59 -1.39 5.72 0.18 26.26
수익의 % 13.54 13.91 14.01 15.11 13.05 12.44 11.31 11.56 10.59 10.20 9.32 8.30 7.73 6.49 5.44 5.18 5.44 5.42 6.90
이자 비용 -9 -9 -9 -9 -10 -12 -13 -12 -12 -14 -23 -41 -55 -83 -104 -123 -136 -135 -134
변화 (%) -0.00 -0.00 -0.00 11.11 20.00 8.33 -7.69 -0.00 16.67 64.29 78.26 34.15 50.91 25.30 18.27 10.57 -0.74 -0.74
수익의 % -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.03 -0.03 -0.03 -0.03 -0.05 -0.09 -0.12 -0.18 -0.21 -0.24 -0.27 -0.26 -0.26
당기순이익 4,750 4,600 4,525 4,668 3,789 3,653 3,350 3,600 3,337 3,390 3,279 3,295 3,230 2,651 2,173 1,908 1,986 2,233 2,958
변화 (%) -3.16 -1.63 3.16 -18.83 -3.59 -8.29 7.46 -7.31 1.59 -3.27 0.49 -1.97 -17.93 -18.03 -12.20 4.09 12.44 32.47
수익의 % 10.16 10.19 10.18 10.74 8.66 8.23 7.54 7.98 7.38 7.39 7.26 7.03 6.82 5.60 4.45 3.77 3.90 4.36 5.83

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista